The pharmaceutical industry continues to pursue the discovery of medicines for cancer patients with unprecedented rigor. Over the past several years, three major trends have reflected this pursuit. They include the growth of the industry pipeline of cancer-drug candidates, the evolution of the clinical-trial landscape, and the explosion of available clinical and real-world data
{iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/pursuing-breakthroughs-in-cancer-drug-development?cid=other-eml-alt-mip-mck-oth-1801&hlkid=ef5891bdbe17465483a9be1c9cf40b32&hctky=3027237&hdpid=dde354f7-3a98-47bd-af33-2eed2ba9ab8b{/iframe}